RHK RHON-KLINIKUM AG

EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Quarter Results/Quarter Results
RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter

08.05.2024 / 08:59 CET/CEST
The issuer is solely responsible for the content of this announcement.


Corporate News  

Bad Neustadt a. d. Saale | 8 May 2024


RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter

 

RHÖN-KLINIKUM AG, one of the leading healthcare providers in Germany, has made a solid start to financial year 2024. Both consolidated profit and EBITDA as well as revenues rose in the first three months.

Revenues increased by 5.9% to €382.8 million (Q1 2023:  €361.5 million). At €25.2 million, EBITDA (earnings before interest, taxes, depreciation and amortisation) was 12% higher than the previous year (Q1 2023: €22.5 million). Taking into account depreciation, amortisation, financing costs and taxes, EBITDA resulted in a consolidated profit of €11.1 million (Q1 2023: €6.4 million). From January to March 2024, 234,151 outpatients and inpatients were treated in the Group's hospitals and medical care centers (Q1 2023: 228,189).

“RHÖN-KLINIKUM AG considers itself well prepared for the forthcoming hospital reform with positioning of its hospitals. With our RHÖN Campus concept, the growing range of outpatient treatment services and the establishment of new medical services, we are seizing opportunities that we will implement for the benefit of our patients”, says Prof. Dr Tobias Kaltenbach, Chairman of the Board of Management of RHÖN-KLINIKUM AG.


Outlook for 2024 confirmed

For the coming financial year, RHÖN-KLINIKUM AG expects revenues of €1.6 billion euros within a range of +/- 5% upwards and downwards respectively. For earnings before interest, tax and depreciation and amortisation (EBITDA), a level of between €110 million euros and €120 million is expected.

This outlook reflects the further tightening of regulatory intervention by the legislator. RHÖN-KLINIKUM AG points out that the outlook is subject to considerable uncertainties in connection with the numerous global crises resulting in inflation and price increases and subject to any regulatory intervention causing the remuneration structure in 2024.


 

RHÖN-KLINIKUM AG is one of the leading healthcare providers in Germany. The hospitals offer excellent medical care with a direct tie-in to universities and research facilities. Each year some 882,000 patients are treated at our five sites – RHÖN-KLINIKUM Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen and Universitätsklinikum Marburg (UKGM) as well as Zentralklinik Bad Berka. The Company employs over 18,200 persons. The innovative RHÖN Campus approach committed to cross-sector and future-oriented healthcare delivery in rural areas, the steadfast continuation of the gradual digital transformation within the Company as well as the strategic partnership with Asklepios are key elements of our corporate strategy. RHÖN-KLINIKUM AG is an independent Company operating under the umbrella of Asklepios Kliniken GmbH & Co. KGaA.


Contact:

RHÖN-KLINIKUM AG |Head of Corporate Finance, Treasury, Investor Relations and Sustainability
Julian Schmitt 
T. 50 |


RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale



08.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at -news.com


Language: English
Company: RHÖN-KLINIKUM Aktiengesellschaft
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Germany
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
E-mail:
Internet: -klinikum-ag.com
ISIN: DE0007042301
WKN: 704230
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1898205

 
End of News EQS News Service

1898205  08.05.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1898205&application_name=news&site_id=research_pool
EN
08/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RHON-KLINIKUM AG

 PRESS RELEASE

EQS-News: RHÖN-KLINIKUM AG startet mit gutem ersten Quartal ins Geschä...

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Schlagwort(e): Quartalsergebnis/Quartalsergebnis RHÖN-KLINIKUM AG startet mit gutem ersten Quartal ins Geschäftsjahr 2024 08.05.2024 / 08:59 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Corporate News Bad Neustadt a. d. Saale | 8. Mai 2024 RHÖN-KLINIKUM AG startet mit gutem ersten Quartal ins Geschäftsjahr 2024   Die RHÖN-KLINIKUM AG, einer der führenden Gesundheitsdienstleister in Deutschland, ist solide ins Geschäftsjahr 2024 gestartet. Sowohl das Konzernergebnis und EBITDA als au...

 PRESS RELEASE

EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good firs...

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Quarter Results/Quarter Results RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter 08.05.2024 / 08:59 CET/CEST The issuer is solely responsible for the content of this announcement. Corporate News   Bad Neustadt a. d. Saale | 8 May 2024 RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter   RHÖN-KLINIKUM AG, one of the leading healthcare providers in Germany, has made a solid start to financial year 2024. Both consolidated profit and EBITDA as well as revenues rose in the fi...

 PRESS RELEASE

EQS-News: RHÖN-KLINIKUM AG schließt Geschäftsjahr 2023 erfolgreich ab

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Schlagwort(e): Jahresergebnis/Jahresergebnis RHÖN-KLINIKUM AG schließt Geschäftsjahr 2023 erfolgreich ab 28.03.2024 / 09:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.   Corporate News Bad Neustadt a. d. Saale | 28. März 2024   RHÖN-KLINIKUM AG schließt Geschäftsjahr 2023 erfolgreich ab Die RHÖN-KLINIKUM AG hat ihre Finanzziele wie prognostiziert erfüllt. Der Umsatz erhöhte sich um 17,9 Mio. Euro auf 1.464,0 Mio. Euro (Vj. 1.446,1 Mio. Euro), trotz Wegfall der Erstattungen des G...

 PRESS RELEASE

EQS-News: RHÖN-KLINIKUM AG looks back on successful financial year 202...

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Annual Results/Annual Results RHÖN-KLINIKUM AG looks back on successful financial year 2023 28.03.2024 / 09:00 CET/CEST The issuer is solely responsible for the content of this announcement.   Corporate News Bad Neustadt a. d. Saale | 28 March 2024   RHÖN-KLINIKUM AG looks back on successful financial year 2023 RHÖN-KLINIKUM AG has met its financial targets as per forecast. Revenues increased by 17.9 million euros to 1,464.0 million euros (previous year: 1,446.1 million euros), despite the discontinuation o...

 PRESS RELEASE

EQS-News: RHÖN-KLINIKUM AG steigert Konzerngewinn und Umsatz

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Schlagwort(e): 9-Monatszahlen/9-Monatszahlen RHÖN-KLINIKUM AG steigert Konzerngewinn und Umsatz 09.11.2023 / 09:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.   Corporate News Bad Neustadt a. d. Saale | 9. November 2023   RHÖN-KLINIKUM AG steigert Konzerngewinn und Umsatz  Die RHÖN-KLINIKUM AG konnte in den ersten neun Monaten 2023 die Umsatzerlöse um 21,7 Mio. Euro auf 1.089,0 Mio. Euro (9M 2022: 1.067,3 Mio. Euro) steigern, trotz Wegfall der Erstattungen des Gesetzgebers im Zus...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch